Immunomedics' $40M Deal Over Data Scandal Gets Initial OK
By Katryna Perera · February 23, 2023, 10:26 PM EST
A New Jersey federal judge granted preliminary approval on Thursday to a $40 million settlement between pharmaceutical company Immunomedics Inc. and a class of its investors that will resolve claims that...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login